148 related articles for article (PubMed ID: 23972547)
1. Drugs induced pulmonary arterial hypertension.
Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced pulmonary arterial hypertension: a recent outbreak.
Montani D; Seferian A; Savale L; Simonneau G; Humbert M
Eur Respir Rev; 2013 Sep; 22(129):244-50. PubMed ID: 23997051
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced pulmonary arterial hypertension: a review.
Garg L; Akbar G; Agrawal S; Agarwal M; Khaddour L; Handa R; Garg A; Shah M; Patel B; Dalal BD
Heart Fail Rev; 2017 May; 22(3):289-297. PubMed ID: 28417295
[TBL] [Abstract][Full Text] [Related]
4. Drug-associated pulmonary arterial hypertension.
McGee M; Whitehead N; Martin J; Collins N
Clin Toxicol (Phila); 2018 Sep; 56(9):801-809. PubMed ID: 29508628
[TBL] [Abstract][Full Text] [Related]
5. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure.
Barst RJ; Abenhaim L
Heart; 2004 Jul; 90(7):e42. PubMed ID: 15201268
[TBL] [Abstract][Full Text] [Related]
6. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL
Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension associated with benfluorex exposure.
Savale L; Chaumais MC; Cottin V; Bergot E; Frachon I; Prevot G; Pison C; Dromer C; Poubeau P; Lamblin N; Habib G; Reynaud-Gaubert M; Bourdin A; Sanchez O; Tubert-Bitter P; Jaïs X; Montani D; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2012 Nov; 40(5):1164-72. PubMed ID: 22523367
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic pulmonary arterial hypertension.
Souza R; Jardim C; Humbert M
Semin Respir Crit Care Med; 2013 Oct; 34(5):560-7. PubMed ID: 24037625
[TBL] [Abstract][Full Text] [Related]
9. Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.
Hagiwara M; Tsuchida A; Hyakkoku M; Nishizato K; Asai T; Nozawa Y; Tsuchihashi K; Shimamoto K
Jpn Circ J; 2000 Mar; 64(3):218-21. PubMed ID: 10732856
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.
Baumgart B; Guha M; Hennan J; Li J; Woicke J; Simic D; Graziano M; Wallis N; Sanderson T; Bunch RT
Cancer Chemother Pharmacol; 2017 Apr; 79(4):711-723. PubMed ID: 28283735
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
[TBL] [Abstract][Full Text] [Related]
12. Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.
de Jesus Perez V; Kudelko K; Snook S; Zamanian RT
Int J Clin Pract Suppl; 2011 Jan; (169):8-10. PubMed ID: 21176010
[TBL] [Abstract][Full Text] [Related]
13. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
14. [Appetite depressants and pulmonary hypertension].
Hellermann J; Salomon F
Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
Natali D; Girerd B; Montani D; Soubrier F; Simonneau G; Humbert M; Sitbon O
Chest; 2011 Oct; 140(4):1066-1068. PubMed ID: 21972386
[TBL] [Abstract][Full Text] [Related]
16. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
Seiler KU; Wassermann O; Wensky H
Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies in pulmonary arterial hypertension.
Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping].
van Wolferen SA; Vonk Noordegraaf A; Boonstra A; Postmus PE
Ned Tijdschr Geneeskd; 2005 Jun; 149(23):1283-8. PubMed ID: 15960135
[TBL] [Abstract][Full Text] [Related]
19. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
20. Benfluorex: increasing reports of valve disorders.
Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
